-
Mashup Score: 1Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD: - 2 year(s) ago
Central Illustration
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract As the clinical applications of immune checkpoint inhibitors (ICIs) expand, our knowledge of the potential adverse effects of these drugs continues to broaden. Emerging evidence supports t…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
From @jaccjournals, over 30% of cancer patients are eligible for an ICI. A review on the potential for ICI related atherosclerosis - JACC: CardioOncology led by the amazing @GiselleSA_MDPhD from @MGHHeartHealth and @MGHCVFellows https://t.co/EuuxbMZQkU
-
-
Mashup Score: 4Longitudinal Right Ventricular Systolic Function Changes in Breast Cancer Patients Treated With Cardiotoxic Cancer Therapy: - 2 year(s) ago
Central Illustration
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
What is the long-term trajectory of RV systolic function in women with breast cancer who receive #doxorubicin and/or #trastuzumab? Find out in this #JACCCardioOnc Research Letter from @BiniyamD et al. https://t.co/HaMqaoSkqv #CardioOnc #BCsm #CardioTwitter https://t.co/DfytZ17nRN
-
-
Mashup Score: 12AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract Amyloid light chain (AL) amyloidosis is a rare, debilitating, often fatal disease. Symptoms of cardiomyopathy are common presenting features, and patients often are referred to cardiologis…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
ICYMI: Read this #JACCCardioOnc state-of-the-art review on everything #cardiologists need to know about AL #amyloidosis: suspecting, diagnosing, treating their patients, including emerging novel treatments. https://t.co/89dYdE8VDl #ALAmyloidosis #BetterOutcomes #CardioOnc https://t.co/deixUrR3fa
-
-
Mashup Score: 2
Abstract The field of cardio-oncology was born from the necessity for recognition and management of cardiovascular diseases among patients with cancer. This need for this specialty continues to gro…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
Permissive cardiotoxicity, a novel terminology, that emphasises continued #cancer therapy if appropriate, while mitigating cardiotoxicities. @jaccjournals https://t.co/VTnomDJMz1
-
-
Mashup Score: 4
Abstract Background Renal cell carcinoma (RCC) can be complicated by a venous tumor thrombus (TT), of which the optimal management is unknown. Objectives This study sought to assess the prevalence …
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
A tumor thrombus is relatively common in renal cell carcinoma patients, & is associated w/ high risk of developing #VTE. Future studies should establish which of these patients benefit from anticoagulation therapy. https://t.co/agMpnCU5Ua #JACCCardioOnc #CardioOnc #cvVTE #cvCoag https://t.co/yVA53KoMki
-
-
Mashup Score: 3
Corresponding Author
Source: JACC: CardioOncologyCategories: Latest Headlines, Oncologists1Tweet-
It was a pleasure to comment on this study and discuss when to include exercise in cancer treatment planning. As an oncologist, I think about this a lot! @JACCJournals #ExOnc #CardioOnc #CardioTwitter @MSKCancerCenter https://t.co/uthQ5bjssG https://t.co/Vh5xnx2w5w https://t.co/gimy0NqDRV
-
-
Mashup Score: 6Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study - 2 year(s) ago
Abstract Background Performance status (PS) is a reliable prognostic tool for overall survival in patients with cancer-associated pulmonary embolism (PE). However, its association with venous throm…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Performance Score is a valuable indicator for predicting #VTE-related outcomes and may inform decision-making regarding anticoagulation during follow-up in patients with cancer-associated PE. https://t.co/sjKy374aZt #JACCCardioOnc #CardioOnc #cvVTE #cvCoag #ECOG #CardioTwitter https://t.co/HBywvtdgC5
-
-
Mashup Score: 6
IntroductionIt is difficult to assign a precise date to the birth of the field of cardio-oncology. Although cardiac effects of anthracyclines have been known for decades, the field as we now know it truly emerged in the early to mid-2000s, largely in response to recognized cardiac toxicities from trastuzumab and vascular endothelial growth factor (VEGF) inhibitors. Since that time, the field has…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
Proud of the series of editorials on the @escardio #CardioOncology guidelines just published in @JACCJournals JACC:CardioOncology. Link attached for ours. The guidelines are a TRUE triumph - but with a major caution⚠️around promoting overscreening. https://t.co/1rawReIb41
-
-
Mashup Score: 1Longitudinal Right Ventricular Systolic Function Changes in Breast Cancer Patients Treated With Cardiotoxic Cancer Therapy: - 2 year(s) ago
Central Illustration
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @nat_ved: https://t.co/PL6G41usIO
-
Congrats to @Daniel_OrenMD on this case challenge now in @JACCJournals #JACCCardioOnc as part of the Immune Therapy Special Issue Read it here ➡️ https://t.co/gbpaNdZRfC https://t.co/m92kdUw6XS